IMMUNOGENECITY OF HEPATITIS B VACCINE IN MAZANDARAN MEDICAL SCIENCES STUDENTS-2004

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ABEDIYAN F.; AJAMI A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES Year:2006 | Volume:16 | Issue:53 Page(s): 72-77

Download Full-Text

Persian Verion

View:

1,680

Download:

Cites:

Information Journal Paper

Title

IMMUNOGENECITY OF HEPATITIS B VACCINE IN MAZANDARAN MEDICAL SCIENCES STUDENTS-2004

Author(s)

ABEDIYAN F. | AJAMI A. | Issue Writer Certificate

Keywords

VACCININATIONQ3

HEPATITIS BQ3

STUDENTSQ2

Abstract

Background and purpose: Vaccination is the most effeetive method of prophylaxy in high risk group of HEPATITIS B. Some individuals faile to respond to triple doses of vaccine which is potentially dangerous. Therefore, immunogenecity of triple doses recombinant HEPATITIS B vaccine was evaluated in a high risk group (medical sciences STUDENTS). Materials and Methods:193 healthy medical sciences STUDENTS immunized with triple doses of recombinant HEPATITIS B vaccine (0, 1, 6 months). 1-2 months after the last dose, serum anti HBS antibody was determined by ELISA method. According to the antibody titer of the vaccinees (IU/L) they were classified into none responder, low, intermediate and high responder. The none responders were recommended for re-vaccination. Results: Three STUDENTS (1.6%) were detected as non responder. (<10 Iu/L anti HBS antibody), 23 (11/4%) as low responder, 141 (73%) as intermediate responder and 26 (13.5%) as high responder. Conclusion: The prevolence of non responders to triple doses of recombinant HEPATITIS B vaccine in medical sciences STUDENTS was very low.

Cites

No record.

References

Cite

APA: Copy

ABEDIYAN, F., & AJAMI, A.. (2006). IMMUNOGENECITY OF HEPATITIS B VACCINE IN MAZANDARAN MEDICAL SCIENCES STUDENTS-2004. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 16(53), 72-77. SID. https://sid.ir/paper/45880/en

Vancouver: Copy

ABEDIYAN F., AJAMI A.. IMMUNOGENECITY OF HEPATITIS B VACCINE IN MAZANDARAN MEDICAL SCIENCES STUDENTS-2004. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2006;16(53):72-77. Available from: https://sid.ir/paper/45880/en

IEEE: Copy

F. ABEDIYAN, and A. AJAMI, “IMMUNOGENECITY OF HEPATITIS B VACCINE IN MAZANDARAN MEDICAL SCIENCES STUDENTS-2004,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 16, no. 53, pp. 72–77, 2006, [Online]. Available: https://sid.ir/paper/45880/en

Related Journal Papers